Zurich Cantonal Bank
ADVM

Zurich Cantonal Bank’s Adverum Biotechnologies ADVM Stock Holding History

Zurich Cantonal Bank’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-765
Closed -$17K – 2906
2021
Q3 		$17K Hold
765
– – ﹤0.01% 2790
2021
Q2 		$27K Hold
765
– – ﹤0.01% 2555
2021
Q1 		$75K Hold
765
– – ﹤0.01% 2263
2020
Q4 		$83K Hold
765
– – ﹤0.01% 2284
2020
Q3 		$79K Hold
765
– – ﹤0.01% 2086
2020
Q2 		$160K Sell
765
-209
-21% -$37K ﹤0.01% 1664
2020
Q1 		$95K Buy
974
+167
+21% +$19.5K ﹤0.01% 1629
2019
Q4 		$93K Buy
+807
New +$71.1K ﹤0.01% 1759

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Zurich Cantonal Bank's ADVM Position: Q4 2021 in Review

Zurich Cantonal Bank sold out of Adverum Biotechnologies (ADVM) in Q4 2021, closing a stake of 765 shares — an estimated $17K sold.

Zurich Cantonal Bank first reported a position in ADVM in Q4 2019 and held it in 8 quarters. The position peaked at $160K in Q2 2020. 98 funds tracked by Wall St. Rank hold ADVM as of Q4 2021.

  • Zurich Cantonal Bank reported no remaining Adverum Biotechnologies position as of Q4 2021 after selling out during the quarter.
  • Zurich Cantonal Bank sold 765 Adverum Biotechnologies shares in Q4 2021, an estimated $17K.
  • Zurich Cantonal Bank first reported a position in Adverum Biotechnologies in Q4 2019 and held it in 8 quarters.
  • Zurich Cantonal Bank's Adverum Biotechnologies position peaked at $160K in Q2 2020.
  • 98 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2021.

Based on Zurich Cantonal Bank's 13F filing for Q4 2021, filed 1 Feb 2022.